Commentaries

Time for a 21st Century Manhattan Project

Politics, incompetence and disorganization got us into this mess. Science, solidarity and discipline can get us out of it. There’s already a blueprint for organizing science and industry to overcome an existential threat. It was...

Promoting more effective biotech boards

Most would agree that the board of directors plays an integral role in the success or failure of biotech companies, but exactly what makes one board highly effective and another complacent isn’t always clear. In...

We’ve moved on from nude women parties. The progress is much bigger than that.

Sunday was International Women’s Day. I looked back at a column I wrote in 2018 wondering how much of it was still relevant. Can something as fundamental as the situation for women in our industry...

Coronavirus crisis calls for competence, clarity and courage at the top

In times of crisis, societies need competence, clarity and courage from their leaders -- qualities that have been in short supply during the COVID-19 outbreak. Now more than ever, agencies like CDC and FDA need...

Coronavirus crisis calls for competence, clarity and courage at the top

In times of crisis, societies need competence, clarity and courage from their leaders -- qualities that have been in short supply during the COVID-19 outbreak. Now more than ever, agencies like CDC and FDA need...

Hidden consequences of COVID-19: Why small biotechs can’t just wait this one out

It’s still anyone’s guess as to how long the COVID-19 outbreak will take to peak, let alone wane after that. But small biotechs could see knock-on effects that play out over a longer time frame...

When single-payer systems adopt innovation better than U.S. commercial payers

It is a truth universally acknowledged, to borrow from Jane Austen, that a single-payer system will say “no” to new technology. If they accept it at all, they do so only when the prices are...

The new drug development -- collaborative and people-powered

In recent years, the healthcare ecosystem has been experiencing a paradigm shift in how it engages with the people at its center: patients. Patients are demanding to be viewed first as people, with lives and...

The AMR crisis is solvable -- but we must act together and fast

Antimicrobial resistance is one of the most serious threats to humanity. This year, a staggering 700,000 people will die from infections that cannot be treated by most or all available antibiotics. Sadly, this number will...

All chips on immuno-oncology is not a good gamble

While first-generation immuno-oncology therapies are only the tip of the iceberg of what immune reprogramming promises to do for patients, the massive investment in the space has entered bubble territory, with the inflating number of...

兑现中国知识产权改进承诺的时机已至

Publisher's note: the English language version of this article may be found here . 两年前的今天, 2017年10月8日, 中共中央和国务院的最高机构制定了知识产权改革的路线, 下决心推动中国进入全球医药创新的生态系统。 可惜这一宏伟规划尚未付诸实施。 当中美谈判代表本周在华盛顿举行新一轮贸易谈判之时, 中国有机会将这一承诺变为现实...

Time to fulfill China’s promise of IP reform

Two years ago, on Oct. 8, 2017, the top bodies of the Chinese Communist Party and the Chinese government created a pathway to IP reform that promised to propel the nation into the global innovation...

Biopharma, patients should demand changes to CFIUS regulation

In a misguided effort to protect U.S. national security, the Treasury Department has proposed barriers to Chinese investments in U.S. biopharma companies that would slow the development of new medicines, constrain funding for emerging companies...

Foreign investment in U.S. biotech will become harder, and stay harder

It would be easy to brush aside the government’s increased scrutiny of foreign investments in U.S. companies in the interest of national security as either a temporary symptom of the trade war or a policy...

Letter to the Editor: Business Roundtable vs. the social contract

In a Sept. 13 Editor’s Comment in BioCentury, our Washington Editor Steve Usdin writes about the importance of the biopharmaceutical industry renewing its commitments to the social contract under which corporations do business and reap...